Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report

Tian, Y; Hu, WT; Yan, Q; Feng, B

Yan, Q; Feng, B (通讯作者)，Tongji Univ, Shanghai East Hosp, Sch Med, Dept Endocrinol, Shanghai 200120, Peoples R China.

MEDICINA-LITHUANIA, 2023; 59 (5):

Abstract

Purpose: Dapagliflozin has been used extensively in patients with type 2 diabetes mellitus (T2DM). However, due to the potential diabetic ketoacidosis......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索